A study of the combined effects of the EHD3 and FREM3 genes in patients with major depressive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 3, 2012, Pages 336-342

  Shi, Cuijuan ^a   Zhang, Kerang ^b   Wang, Xuan ^a,c   Shen, Yan ^a   Xu, Qi ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c BEIJING HUILONGGUAN HOSPITAL   (China)

Author keywords

Combined effect; EHD3; FREM3; Genome wide association study; Major depressive disorder

Indexed keywords

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; EHD3 GENE; FEMALE; FREM3 GENE; GENE; GENE CONSTRUCT; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOTE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHINA; DEPRESSIVE DISORDER, MAJOR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84863230172     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32033     Document Type: Article

References (34)

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders 4th ed. Washington, DC: American Psychiatric Press.
2. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263- 265.
3. Belmaker RH, Agam G. 2008. Major depressive disorder. N Engl J Med 358(1): 55- 68.
4. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ. 2011. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16(6): 634- 646.
5. Cantor RM, Lange K, Sinsheimer JS. 2010. Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet 86(1): 6- 22.
6. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, Myers RM, Bunney WE Jr, Akil H, Watson SJ, et al. 2005. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 102(43): 15653- 15658.
7. Conrad DF, Jakobsson M, Coop G, Wen X, Wall JD, Rosenberg NA, Pritchard JK. 2006. A worldwide survey of haplotype variation and linkage disequilibrium in the human genome. Nat Genet 38(11): 1251- 1260.
8. D'Sa C, Duman RS. 2002. Antidepressants and neuroplasticity. Bipolar Disord 4(3): 183- 194.
9. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2): 115- 121.
10. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66(2): 87- 98.
11. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. 2007. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64(2): 193- 200.
12. Hirling H. 2009. Endosomal trafficking of AMPA-type glutamate receptors. Neuroscience 158(1): 36- 44.
13. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. 2003. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23): 3095- 3105.
14. Klein DN, Lewinsohn PM, Seeley JR, Rohde P. 2001. A family study of major depressive disorder in a community sample of adolescents. Arch Gen Psychiatry 58(1): 13- 20.
15. Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P. 2001. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40(8): 1028- 1033.
16. Liu IC, Chiu CH. 2009. Case-control study of suicide attempts in the elderly. Int Psychogeriatr 21(5): 896- 902.
17. Lopez AD, Mathers CD. 2006. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol 100(5-6): 481- 499.
18. Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, et al. 2010. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 15(6): 589- 601.
19. Naslavsky N, Rahajeng J, Sharma M, Jovic M, Caplan S. 2006. Interactions between EHD proteins and Rab11-FIP2: A role for EHD3 in early endosomal transport. Mol Biol Cell 17(1): 163- 177.
20. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al. 2008. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40(9): 1053- 1055.
21. Park M, Penick EC, Edwards JG, Kauer JA, Ehlers MD. 2004. Recycling endosomes supply AMPA receptors for LTP. Science 305(5692): 1972- 1975.
22. Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, Li X, Zhang Y, Wang Z. 2009. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: An epidemiological survey. Lancet 373(9680): 2041- 2053.
23. Saad M, Lesage S, Saint-Pierre A, Corvol JC, Zelenika D, Lambert JC, Vidailhet M, Mellick GD, Lohmann E, Durif F, et al. 2011. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 20(3): 615- 627.
24. Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR Jr, Gejman PV, Sanders AR, et al. 2011. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 16(2): 193- 201.
25. Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM, Garriock HA, Yokoyama JS, McGrath PJ, Peters EJ, et al. 2011. Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry 16(2): 202- 215.
26. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, et al. 2007. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445(7130): 881- 885.
27. Smyth I, Du X, Taylor MS, Justice MJ, Beutler B, Jackson IJ. 2004. The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. Proc Natl Acad Sci USA 101(37): 13560- 13565.
28. Steunenberg B, Beekman AT, Deeg DJ, Kerkhof AJ. 2010. Personality predicts recurrence of late-life depression. J Affect Disord 123(1-3): 164- 172.
29. Sullivan PF, de Geus EJ, Willemsen G, James MR, Smit JH, Zandbelt T, Arolt V, Baune BT, Blackwood D, Cichon S, et al. 2009. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol Psychiatry 14(4): 359- 375.
30. Sullivan PF, Neale MC, Kendler KS. 2000. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 157(10): 1552- 1562.
31. Takamiya K, Kostourou V, Adams S, Jadeja S, Chalepakis G, Scambler PJ, Huganir RL, Adams RH. 2004. A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1. Nat Genet 36(2): 172- 177.
32. The Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447(7145): 661- 678.
33. Wray NR, Pergadia ML, Blackwood DH, Penninx BW, Gordon SD, Nyholt DR, Ripke S, MacIntyre DJ, McGhee KA, Maclean AW, et al. 2012. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry 17(1): 36- 48.
34. Zhang J, Chen Y, Zhang K, Yang H, Sun Y, Fang Y, Shen Y, Xu Q. 2010. A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biol Psychiatry 68(9): 795- 800.